Regulations.gov document
Reference 10 - Food and Drug Administration Supplemental Review of Oxitriptan, November…
Supporting & Related Material · FDA-2016-N-3464 · posted Feb 19, 2019
Key facts
| Document ID | FDA-2016-N-3464-0032 |
|---|---|
| Title | Reference 10 - Food and Drug Administration Supplemental Review of Oxitriptan, November 2018. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-N-3464 |
| Posted | Feb 19, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: